Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Shares Issued: 2017-2020

Historic Shares Issued for Monopar Therapeutics (MNPR) over the last 2 years, with Sep 2020 value amounting to -$1.4 million.

  • Monopar Therapeutics' Shares Issued was N/A to -$1.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $10.2 million, marking a year-over-year change of. This contributed to the annual value of $37.4 million for FY2024, which is 1702.05% up from last year.
  • As of Q3 2020, Monopar Therapeutics' Shares Issued stood at -$1.4 million, which was down 255.61% from $913,525 recorded in Q2 2020.
  • Over the past 5 years, Monopar Therapeutics' Shares Issued peaked at $10.2 million during Q4 2019, and registered a low of -$1.4 million during Q3 2020.
  • Its 2-year average for Shares Issued is $2.6 million, with a median of $710,784 in 2020.